Targeting of Jak/STAT Pathway in Antigen Presenting Cells in Cancer

Publisher： Bentham Science Publishers

E-ISSN： 1873-5576|7|1|71-77

ISSN： 1568-0096

Source： Current Cancer Drug Targets, Vol.7, Iss.1, 2007-02, pp. : 71-77

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Targeting the JAK-STAT pathway in lymphoma: a focus on pacritinib

By Derenzini Enrico  

Expert Opinion on Investigational Drugs, Vol. 22, Iss. 6, 2013-09 ,pp. : 775-785

Informa Healthcare

Access to resources Recommend Favorite

The JAK-STAT Pathway: A Therapeutic Target in Hematological Malignancies

By  

Current Cancer Drug Targets, Vol. 6, Iss. 8, 2006-01 ,pp. : 671-679

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting the STAT Pathway in Head and Neck Cancer: Recent Advances and Future Prospects

By  

Current Cancer Drug Targets, Vol. 4, Iss. 8, 2004-12 ,pp. : 637-651

Bentham Science Publishers

Access to resources Recommend Favorite

IL-6 Activated JAK/STAT3 Pathway and Sensitivity to Hsp90 Inhibitors in Multiple Myeloma

By  

Current Medicinal Chemistry, Vol. 21, Iss. 26, 2014-09 ,pp. : 3042-3047

Bentham Science Publishers

Access to resources Recommend Favorite

Changes in the Expression Profile of JAK/STAT Signaling Pathway Genes and Mirnas Regulating their Expression Under the Adalimumab Therapy

By  

Current Pharmaceutical Biotechnology, Vol. 19, Iss. 7, 2018-06 ,pp. : 556-565

Bentham Science Publishers

Access to resources Recommend Favorite